Folate binding protein - Outlook for drug delivery applications

Chinese Chemical Letters

Volumn 26, Issue 4, 2015, Pages 426-430

  Merzel, Rachel L ^a   Chen, Jun Jie ^a   Marsh, E Neil G ^a   Holl, Mark M Banaszak ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Drug delivery; Folate binding protein; Folate conjugate; Folic acid; Serum protein

Indexed keywords

EID: 84939972993     PISSN: 10018417     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cclet.2014.12.015     Document Type: Article

References (63)

1. Y. Shen, J.M. Jacobs, and D.G. Camp Ultra-high-efficiency strong cation exchange LC/RPLC/MS/MS for high dynamic range characterization of the human plasma proteome Anal. Chem. 76 2004 1134 1144
2. I. Lynch, and K.A. Dawson Protein-nanoparticle interactions Nano Today 3 2008 40 47
3. F. Kratz, and B. Elsadek Clinical impact of serum proteins on drug delivery J. Controlled Release 161 2012 429 445
4. A.M. Merlot, D.S. Kalinowski, and D.R. Richardson Unraveling the mysteries of serum albumin - more than just a serum protein Front. Physiol. 5 2014 1 7
5. B. Elsadek, and F. Kratz Impact of albumin on drug delivery - new applications on the horizon J Controlled Release 157 2012 4 28
6. F. Kratz Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles J Controlled Release 132 2008 171 183
7. Q. Chen, C. Liang, and X. Wang An albumin-based theranostic nano-agent for dual-modal imaging guided photothermal therapy to inhibit lymphatic metastasis of cancer post surgery Biomaterials 35 2014 9355 9362
8. Q. Chen, C. Wang, and Z.X. Zhan Near-infrared dye bound albumin with separated imaging and therapy wavelength channels for imaging-guided photothermal therapy Biomaterials 35 2014 8206 8214
9. A.N. Luck, and A.B. Mason Structure and dynamics of drug carriers and their interaction with cellular receptors: focus on serum transferrin Adv. Drug Delivery Rev. 65 2013 1012 1019
10. C.P. Leamon Folate-targeted drug strategies for the treatment of cancer Curr. Opin. Invest. Drugs 9 2008 1277 1286
11. P.S. Low, W.A. Henne, and D.D. Doorneweerd Discovery and development of folic-acid-based receptor targeting for Imaging and therapy of cancer and inflammatory diseases Acc. Chem. Res. 41 2008 120 129
12. I.M. Kompis, K. Islam, and R.L. Then DNA and RNA synthesis: antifolates Chem. Rev. 105 2005 593 620
13. M. Sharma, and P.M.S. Chauhan Dihydrofolate reductase as a therapeutic target for infectious diseases: opportunities and challenges Future Med. Chem. 4 2012 1335 1365
14. A.S. Wibowo, M. Singh, and K.M. Reeder Structures of human folate receptors reveal biological trafficking states and diversity in folate and antifolate recognition Proc. Natl. Acad. Sci. U.S.A. 110 2013 15180 15188
15. C. Chen, J. Ke, and X.E. Zhou Structural basis for molecular recognition of folic acid by folate receptors Nature 500 2013 486 490
16. J. Ghitis Folate binding in milk Am. J. Clin. Nutr. 20 1967 1 4
17. M. Hoier-Madsen, J. Holm, and S.I. Hansen Alpha isoforms of soluble and membrane-linked folate-binding protein in human blood Biosci. Rep. 28 2008 153 160
18. A.C. Antony Folate receptors Annu. Rev. Nutr. 16 1996 501 521
19. G.B. Henderson Folate binding proteins Annu. Rev. Nutr. 10 1990
20. J. Holm, L.N. Babol, N. Markova, A.J. Lawaetz, and S.I. Hansen The interrelationship between ligand binding and thermal unfolding of the folate binding protein. The role of self-association and pH Biochim. Biophys. Acta - Proteins Proteomics 1844 2014 512 519
21. B.A. Kamen Folate receptors and therapeutic applications A.L. Jackman, C.P. Leamon, Targeted Drug Strategies for Cancer and Inflammation 2011 Springer New York
22. L. Nygren-Babol, and M. Jagerstad Folate-binding protein in milk: a review of biochemistry, physiology, and analytical methods Crit. Rev. Food Sci. Nutr. 52 2012 410 425
23. N. Grossowicz Purification and properties of the folate-binding protein Methods Enzymol. 66 1980 690 694
24. T. Treloar, P.A. Grieve, and P.F. Nixon One-step affinity purification of folate-binding protein, a minor whey protein Aust. J. Dairy Technol. 59 2000 96
25. I. Svendsen, B. Martin, and T.G. Pedersen Isolation and characterization of the folate-binding protein from cows milk Carlsberg Res. Commun. 44 1979 89 99
26. I.B. Svendsen, S.I. Hansen, J. Holm, and J. Lyngbye The complete amino-acid-sequence of the folate-binding protein from cows milk Carlsberg Res. Commun. 49 1984 123 131
27. S.J. Roberts, M. Petropavlovskaja, K.N. Chung, C.B. Knight, and P.C. Elwood Role of individual N-linked glycosylation sites in the function and intracellular transport of the human alpha folate receptor Arch. Biochem. Biophys. 351 1998 227 235
28. M. Ratnam, H. Marquardt, J.L. Duhring, and J.H. Freisheim Homologous membrane folate binding-proteins in human-placenta - cloning and sequence of a cDNA Biochemistry 28 1989 8249 8254
29. C.A. Luhrs The role of glycosylation in the biosynthesis and acquisition of ligand-binding activity of the folate-binding protein in cultured Kb cells Blood 77 1991 1171 1180
30. S.W. Bruun, J. Holm, S.I. Hansen, C.M. Andersen, and L. Norgaard A chemometric analysis of ligand-induced changes in intrinsic fluorescence of folate binding protein indicates a link between altered conformational structure and physico-chemical characteristics Appl. Spectrosc. 63 2009 1315 1322
31. J. Holm, A.J. Lawaetz, and S.I. Hansen Ligand binding induces a sharp decrease in hydrophobicity of folate binding protein assessed by 1-anilinonaphthalene-8-sulphonate which suppresses self-association of the hydrophobic apo-protein Biochem. Biophys. Res. Commun. 425 2012 19 24
32. E.J. Smart, C. Mineo, and R.G.W. Anderson Clustered folate receptors deliver 5-methyltetrahydrofolate to cytoplasm of MA104 cells J. Cell Biol. 134 1996 1169 1177
33. E. Moradi, D. Vllasaliu, M. Garnett, F. Falcone, and S. Stolnik Ligand density and clustering effects on endocytosis of folate modified nanoparticles RSC Adv. 2 2012 3025 3033
34. H. Birn, X.Y. Zhai, and J. Holm Megalin binds and mediates cellular internalization of folate binding protein FEBS J. 272 2005 4423 4430
35. M.J. Sculley, J.F. Morrison, and W.W. Cleland Slow-binding inhibition: the general case Biochim. Biophys. Acta 1298 1996 78 86
36. U. Christensen, J. Holm, and S.I. Hansen Stopped-flow kinetic studies of the interaction of bovine folate binding protein (FBP) and folate Biosci. Rep. 26 2006 291 299
37. S.I. Hansen, J. Holm, J. Lyngbye, T.G. Pedersen, and I. Svendsen Dependence of aggregation and ligand affinity on the concentration of the folate-binding protein from cows milk Arch. Biochem. Biophys. 226 1983 636 642
38. T.G. Pedersen, I.B. Svendsen, S.I. Hansen, J. Holm, and J. Lyngbye Aggregation of a folate-binding protein from cows milk Carlsberg Res. Commun. 45 1980 161 166
39. X. Shi, X. Bi, and T.R. Ganser HPLC Analysis of functionalized poly(amidoamine) dendrimers and the interaction between a folate-dendrimer conjugate and folate binding protein Analyst 131 2006 842 848
40. L.E. Kelderhouse, V. Chelvam, and C. Wayua Development of tumor-targeted near infrared probes for fluorescence guided surgery Bioconj. Chem. 24 2013 1075 1080
41. G.M. van Dam, G. Themelis, and L.M.A. Crane Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-alpha targeting: first in-human results Nat. Med. 17 2011 1315-1319
42. M.D. Kennedy, K.N. Jallad, D.H. Thompson, D. Ben-Amotz, and P.S. Low Optical imaging of metastatic tumors using a folate-targeted fluorescent probe J. Biomed. Opt. 8 2003 636 641
43. P.S. Low, and S.A. Kularatne Folate-targeted therapeutic and imaging agents for cancer Curr. Opin. Chem. Biol. 13 2009 256 262
44. Q. Chen, K.A. Li, and S.H. Wen Targeted CT/MR dual mode imaging of tumors using multifunctional dendrimer-entrapped gold nanoparticles Biomaterials 34 2013 5200 5209
45. J.C. Li, L.F. Zheng, and H.D. Cai Polyethyleneimine-mediated synthesis of folic acid-targeted iron oxide nanoparticles for in vivo tumor MR imaging Biomaterials 34 2013 8382 8392
46. Y. Wang, R. Guo, X. Cao, M. Shen, and X. Shi Encapsulation of 2-methoxyestradiol within multifunctional poly(amidoamine) dendrimers for targeted cancer therapy Biomaterials 2011 2011 3322 3329
47. P. Chen, J. Qin, and B. Zhou Targeted tumor CT imaging using folic acid-modified PEGylated dendrimer-entrapped gold nanoparticles Polym. Chem. 4 2013 4412 4424
48. H. Lui, Y. Xu, and S. Wen Targeted tumor computed tomagraphy imaging using low-generation dendrimer-stabilized gold nanoparticles Chem. Eur. J. 19 2013 6409 6416
49. S. Wen, H. Liu, H. Cai, M. Shen, and X. Shi Targeted and pH-responsive delivery of doxorubicin to cancer cells using multifunctional dendrimer-modified multi-walled carbon nanotubes Adv. Healthc. Mater. 2 2013 1267 1276
50. X.H. Liang, Y. Sun, and L.S. Liu Regioselective synthesis and initial evaluation of a folate receptor targeted rhaponticin prodrug Chin. Chem. Lett. 23 2012 1133 1136
51. A. Gabizon, A.T. Horowitz, and D. Goren Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studies Bioconj. Chem. 10 1999 289 298
52. J.F. Kukowska-Latallo, K.A. Candido, and Z.Y. Cao Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer Cancer Res. 65 2005 5317 5324
53. J.E. Silpe, M. Sumit, and T.P. Thomas Avidity modulation of folated-targeted multivalent dendrimers for evaluating biophysical models of cancer targeting nanoparticles ACS Chem. Biol. 8 2013 2063 2071
54. Y. Zhang, M.Y. Xu, T.K. Jiang, W.Z. Huang, and J.Y. Wu Low generational polyamidoamine dendrimers to enhance the solubiity of folic acid: a "dendritic effect" investigation Chin. Chem. Lett. 25 2014 815 818
55. S. Sunoqrot, J. Bugno, D. Lantvit, J.E. Burdette, and S. Hong Prolonged blood circulation and enhanced tumor accumulation of folate-targeted dendrimer-polymer hybrid nanoparticles J. Controlled Release 191 2014 115 122
56. S. Hong, P.R. Leroueil, and I. Majoros The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform Chem. Biol. 14 2007 107 115
57. M.A. van Dongen, J.E. Silpe, and C.A. Dougherty Avidity mechanism of dendrimer-folic acid conjugates Mol. Pharmaceutics 11 2014 1696 1706
58. M.A. van Dongen, R. Rattan, and J.E. Silpe Poly(amidoamine) dendrimer-methotrexate conjugates: the mechanism of interaction with folate binding protein Mol. Pharmaceutics 11 2014 4049 4058
59. J.J. McGuire Anticancer antifolates: current status and future directions Curr. Pharm. Des. 9 2003 2593 2613
60. H.Y. Xue, and H.L. Wong Targeting megalin to enhance delivery of anti-clusterin small-interfering RNA nanomedicine to chemo-treated breast cancer Eur. J. Pharm. Biopharm. 81 2012 24 32
61. S.K. Holt, D.M. Karyadi, and E.M. Kwon Association of Megalin genetic polymorphisms with prostate cancer risk and prognosis Clin. Cancer Res. 14 2008 3823 3831
62. I.B. Muller, and J.E. Hyde Antimalarial drugs: modes of action and mechanisms of parasite resistance Future Microbiol. 5 2010 1857 1873
63. M. Schlitzer Malaria chemotherapeutics. Part 1: History of antimalarial drug development, currently used therapeutics, and drugs in clinical development ChemMedChem 2 2007 944 986